logoTry Persana

Correlia Biosystems - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Correlia Biosystems including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Correlia Biosystems company logo

Next-gen instruments for quantitative protein measurement (We are hiring, check indeed for positions)

Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules.

HeadquartersBerkeley, United States
Team size1-10
FoundedNA

What is Correlia Biosystems? - Company Overview & Details

Correlia Biosystems is Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules., the company is headquartered in Berkeley, United States.

Who Founded Correlia Biosystems?

Correlia Biosystems was founded by Akwasi Apori, Kursad Araz.

Who are the Key Executives at Correlia Biosystems? - Leadership Team

Correlia Biosystems is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Correlia Biosystems

Akwasi AporiCEO

Chief Technology Officer (CTO) of Correlia Biosystems

Kursad Araz, Ph.D.CTO

About Akwasi Apori - CEO of Correlia Biosystems

Akwasi Apori serves as the Chief Executive Officer of Correlia Biosystems, leading the company's strategic vision and operations.

Correlia Biosystems Company Details & Key Information

Where is Correlia Biosystems located?

Correlia Biosystems is headquartered in Berkeley, United States.

How many employees does Correlia Biosystems have?

Correlia Biosystems has 1-10 employees.

Correlia Biosystems Official Website

How much funding has Correlia Biosystems raised?

Correlia Biosystems has raised $9.6 Million across 9 funding rounds. The most recent funding was completed on 2020-11-20.

Funding Overview

Correlia Biosystems closed a $7 million Series A financing round to enable the commercial launch of its immunoassay platform.

$9.6 Million
Total Funding Raised
9
Funding Rounds
2020-11-20
Latest Round

Correlia Biosystems Funding History

Series A
2020-11-20
$7 Million

Who are the key investors in Correlia Biosystems?

Correlia Biosystems is backed by 3 key investors including Neotribe Ventures, Cota Capital, The Regents of the University of California. These investors focus on sectors.

Correlia Biosystems Investor Overview

3
Key Investors
1
Focus Areas
0
Notable Investments

Complete List of Correlia Biosystems Investors

Neotribe Ventures

Cota Capital

The Regents of the University of California

What sectors do Correlia Biosystems investors focus on?

The investors backing Correlia Biosystems primarily focus on sectors.

Featured Investor: Neotribe Ventures

Neotribe Ventures

Notable Investments:

What are Correlia Biosystems's future plans?

Correlia Biosystems Correlia Biosystems aims to expand its product offerings and enhance research capabilities through innovative technology.

Correlia Biosystems Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Correlia Biosystems face?

Correlia Biosystems has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Correlia Biosystems

1

Market competition

2

Continuous innovation requirements

What opportunities does Correlia Biosystems have?

Correlia Biosystems has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Correlia Biosystems

1

Expansion of early access program

2

Development of multi-plex assays

Correlia Biosystems Strategic Position Summary

Key Focus Areas

Correlia Biosystems is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Correlia Biosystems?

Correlia Biosystems has 2 recent news updates covering key business developments and market activities.

Correlia Biosystems News Overview

2
Recent Articles
Active
Media Coverage
2023-09-07
Latest Update

What is Correlia Biosystems in the news for?

Correlia Biosystems is currently featured in news for Correliabio launches ELISA platform. and other significant business developments.

Recent News Articles About Correlia Biosystems

Article 1
2023-09-07

Correliabio launches ELISA platform.

Correlia Biosystems' PIXI: setting new standards in biotech lab analysis.

bonnevillelabs.com
Read News
Article 2
2020-11-20

Correliabio received financing of $7M in Series A on Nov 20th '20.

Correlia Biosystems announced it has closed a $7 million Series A financing round.

prnewswire.com
Read News

Correlia Biosystems FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Correlia Biosystems including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

Correlia Biosystems Questions & Answers - Company Information

Q1

What is Correlia Biosystems?

Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules.

Q2

Who founded Correlia Biosystems?

Correlia Biosystems was founded by Akwasi Apori, Kursad Araz.

Q3

Who is the CEO of Correlia Biosystems?

The CEO of Correlia Biosystems is Akwasi Apori.

Q4

How much funding has Correlia Biosystems raised?

Correlia Biosystems has raised a total of $$9.6 Million across 9 funding rounds. The most recent funding was completed on 2020-11-20.

Q5

Who are the investors in Correlia Biosystems?

Correlia Biosystems's key investors include Neotribe Ventures, Cota Capital, The Regents of the University of California.

Q6

Where is Correlia Biosystems headquartered?

Correlia Biosystems is headquartered in Berkeley, United States.

Q7

How many employees does Correlia Biosystems have?

Correlia Biosystems has 1-10 employees.

Q8

What is Correlia Biosystems's official website?

You can visit Correlia Biosystems's official website at http://www.correliabio.com.

Q9

What was Correlia Biosystems's latest funding round?

Correlia Biosystems's latest funding round was a Series A round of $$7 Million completed on 2020-11-20.

Q10

Who is founder?

Akwasi Apori

Q11

Who is cto?

Kursad Araz, Ph.D.

Q12

What does the company do?

Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules.

Q13

How much funding?

$9.6 Million

Q14

Latest funding date?

2020-11-20

Q15

Who are the investors?

Neotribe Ventures Cota Capital The Regents of the University of California

Q16

What are the challenges?

Market competition Continuous innovation requirements

Q17

What are the opportunities?

Expansion of early access program Development of multi-plex assays

Q18

Latest news?

Correlia Biosystems' PIXI: setting new standards in biotech lab analysis. Correlia Biosystems announced it has closed a $7 million Series A financing round.

More Information About Correlia Biosystems

For additional details about Correlia Biosystems, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.